A little-known life sciences and biopharma hedge fund specialist is launching its fourth private equity fund.Cormorant Asset Management disclosed in a regulatory filing it has raised nearly $253 million from 34 investors for Cormorant Private Healthcare Fund IV.It is targeting a total of $400 million,